Azimuth Capital Investment Management LLC Edwards Lifesciences Corp Transaction History

Azimuth Capital Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $145,418 - $196,004	-2,099 Reduced 2.27%	90,483 $6.27 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $137,827 - $159,700	-1,693 Reduced 1.8%	92,582 $8.73 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $208,596 - $237,388	-2,809 Reduced 2.89%	94,275 $7.8 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $243,079 - $311,198	-3,559 Reduced 3.54%	97,084 $7.24 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $65,319 - $85,080	-793 Reduced 0.78%	100,643 $8.32 Million
Q2 2022 Aug 11, 2022	BUY	$86.5 - $128.27 $8.77 Million - $13 Million	101,436 New	101,436 $9.65 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Azimuth Capital Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Azimuth Capital Investment Management LLC with notifications on news.